title: [Plea for advancement of the age of vaccination against human papillomavirus in France: Position of the Pediatric Infections Pathology Group (GPIP) and the French Association of Ambulatory Pediatrics (AFPA)].
abstract: Vaccination against human papillomavirus (HPV) is recommended in France at 14 years. The Groupe de Pathologie Infectieuse Pédiatrique de la Société Française de Pédiatrie takes a clear position for advancement of age of vaccination at 11-12 years based on the following arguments: (i) data on the long-term persistence of protective antibodies are reassuring; (ii) these vaccines can be co-administered with vaccines recommended in the current immunization schedule at this age; (iii) actually, nearly 20% of adolescents have had sexual intercourse when the vaccination schedule is finished; (iv) vaccination beyond 14 years increases the risk of occurrence of coincidental autoimmune diseases; (v) the immunogenicity of vaccines against HPV is better when they are administered before age 15; (vi) finally, especially by reducing the number of injections from 3 to 2, the immunization at 11-12 years could improve immunization coverage which is insufficient nowadays.
authors.affiliation: Centre Hospitalier intercommunal de Créteil, 40, avenue de Verdun, 94010 Créteil cedex, France. robert.cohen@wanadoo.fr
authors.forename: R
authors.initials: R
authors.lastname: Cohen
authors.forename: F
authors.initials: F
authors.lastname: Vié Le Sage
authors.forename: C
authors.initials: C
authors.lastname: Weil-Olivier
authors.forename: O
authors.initials: O
authors.lastname: Romain
authors.forename: I
authors.initials: I
authors.lastname: Hau
authors.forename: N
authors.initials: N
authors.lastname: Guérin
authors.forename: G
authors.initials: G
authors.lastname: Thiebault
authors.forename: B
authors.initials: B
authors.lastname: Virey
authors.forename: P
authors.initials: P
authors.lastname: Bakhache
authors.forename: M-A
authors.initials: MA
authors.lastname: Dommergues
authors.forename: J
authors.initials: J
authors.lastname: Gaudelus
mesh_terms: D000293:Adolescent; D000367:Age Factors; D002648:Child; D005260:Female; D005602:France; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D014611:Vaccination
chemical_list: D053918:Papillomavirus Vaccines